At a glance
- Originator Novo Nordisk
- Class Neuroprotectants; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 13 Mar 1997 No-Development-Reported for Neurological disorders (Prevention) in Denmark (Unknown route)